Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles

被引:256
作者
Anselmo, Aaron C. [1 ]
Mitragotri, Samir [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem Engn, Ctr Bioengn, Santa Barbara, CA 93106 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Cellular hitchhiking; Cell-mediated drug delivery; Nanomedicine; Nanotechnology; Nanoparticles; Blood; RED-BLOOD-CELLS; PULSED DENDRITIC CELLS; PLATELET-RICH PLASMA; CANCER-IMMUNOTHERAPY; POLYMERIC NANOPARTICLES; DRUG-DELIVERY; T-CELLS; SYNTHETIC NANOPARTICLES; ADOPTIVE IMMUNOTHERAPY; LOADED ERYTHROCYTES;
D O I
10.1016/j.jconrel.2014.03.050
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Cellular hitchhiking leverages the use of circulatory cells to enhance the biological outcome of nanoparticle drug delivery systems, which often suffer from poor circulation time and limited targeting. Cellular hitchhiking utilizes the natural abilities of circulatory cells to: (i) navigate the vasculature while avoiding immune system clearance, (ii) remain relatively inert until needed and (iii) perform specific functions, including nutrient delivery to tissues, clearance of pathogens, and immune system surveillance. A variety of synthetic nanoparticles attempt to mimic these functional attributes of circulatory cells for drug delivery purposes. By combining the advantages of circulatory cells and synthetic nanoparticles, many advanced drug delivery systems have been developed that adopt the concept of cellular hitchhiking. Here, we review the development and specific applications of cellular hitchhiking-based drug delivery systems. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:531 / 541
页数:11
相关论文
共 81 条
[1]
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage [J].
Abu Lila, Amr S. ;
Kiwada, Hiroshi ;
Ishida, Tatsuhiro .
JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) :38-47
[2]
Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells [J].
Anselmo, Aaron C. ;
Gupta, Vivek ;
Zern, Blaine J. ;
Pan, Daniel ;
Zakrewsky, Michael ;
Muzykantov, Vladimir ;
Mitragotri, Samir .
ACS NANO, 2013, 7 (12) :11129-11137
[3]
Cytotoxic T lymphocytes: All roads lead to death [J].
Barry, M ;
Bleackley, RC .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :401-409
[4]
A macrophage-nanozyme delivery system for Parkinson's disease [J].
Batrakova, Elena V. ;
Li, Shu ;
Reynolds, Ashley D. ;
Mosley, R. Lee ;
Bronich, Tatiana K. ;
Kabanov, Alexander V. ;
Gendelman, Howard E. .
BIOCONJUGATE CHEMISTRY, 2007, 18 (05) :1498-1506
[5]
Cell-mediated drug delivery [J].
Batrakova, Elena V. ;
Gendelman, Howard E. ;
Kabanov, Alexander V. .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (04) :415-433
[6]
Brynskikh AM, 2010, NANOMEDICINE-UK, V5, P379, DOI [10.2217/nnm.10.7, 10.2217/NNM.10.7]
[7]
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine [J].
Caplan, Arnold I. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 213 (02) :341-347
[8]
Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes [J].
Chambers, E ;
Mitragotri, S .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :111-119
[9]
Chambers E, 2007, EXP BIOL MED, V232, P958
[10]
NK cell-based immunotherapy for malignant diseases [J].
Cheng, Min ;
Chen, Yongyan ;
Xiao, Weihua ;
Sun, Rui ;
Tian, Zhigang .
CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (03) :230-252